Cargando…

Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer

BACKGROUND: Excessive skeletal muscle loss during neoadjuvant concurrent chemoradiotherapy (NACRT) is significantly related to survival outcomes of oesophageal cancer. However, the conventional method for measuring skeletal muscle mass requires computed tomography (CT) images, and the calculation pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Han Gyul, Oh, Dongryul, Noh, Jae Myoung, Cho, Won Kyung, Sun, Jong‐Mu, Kim, Hong Kwan, Zo, Jae Ill, Shim, Young Mog, Kim, Kyunga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517349/ https://www.ncbi.nlm.nih.gov/pubmed/34145771 http://dx.doi.org/10.1002/jcsm.12747

Ejemplares similares

Feasibility of an Interactive Health Coaching Mobile App to Prevent Malnutrition and Muscle Loss in Esophageal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy: Prospective Pilot Study
por: Yang, Kyungmi, et al.
Publicado: (2021)

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer
por: Yoon, Han Gyul, et al.
Publicado: (2020)

Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery
por: Cho, Won Kyung, et al.
Publicado: (2016)

Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion
por: Kim, Hakyoung, et al.
Publicado: (2018)

Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
por: Shin, Sumin, et al.
Publicado: (2020)

Esophageal Cancer: Overcome the Hurdles and Reach for the Cure
por: Kim, Hong Kwan, et al.
Publicado: (2020)

The Role of Adjuvant Chemotherapy after Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Esophageal Squamous Cell Carcinoma
por: Park, Seong Yong, et al.
Publicado: (2023)

Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience
por: Park, Hyojung, et al.
Publicado: (2017)

Higher thoracic radiation dose is beneficial in patients with extensive small cell lung cancer
por: Yoon, Han Gyul, et al.
Publicado: (2019)

Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy?
por: Chong, Yousun, et al.
Publicado: (2014)

High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma
por: Hong, Min Hee, et al.
Publicado: (2019)

The major effects of health-related quality of life on 5-year survival prediction among lung cancer survivors: applications of machine learning
por: Sim, Jin-ah, et al.
Publicado: (2020)

Management of post‐pneumonectomy syndrome using tissue expanders
por: Jung, Jae Jun, et al.
Publicado: (2015)

Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System
por: Lee, Hyunjong, et al.
Publicado: (2022)

Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
por: Hagens, E. R. C., et al.
Publicado: (2020)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Predictors of survival in patients who underwent video‐assisted thoracic surgery talc pleurodesis for malignant pleural effusion
por: Yoon, Dong Woog, et al.
Publicado: (2016)

Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy
por: Yoshikawa, R, et al.
Publicado: (2008)

Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer
por: Vollenbrock, S. E., et al.
Publicado: (2019)

The prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer
por: Cho, Jong Ho, et al.
Publicado: (2015)

Intensive care unit (ICU) readmission after major lung resection: Prevalence, patterns, and mortality
por: Jung, Jae Jun, et al.
Publicado: (2016)

Primary Chest Wall Sarcoma: Surgical Outcomes and Prognostic Factors
por: Park, Ilkun, et al.
Publicado: (2019)

Prognostic impact of lymph node ratio in patients with pT1–2N1M0 non-small cell lung cancer
por: Shin, Sumin, et al.
Publicado: (2020)

Liquid biopsy using cfDNA to predict radiation therapy response in solid tumors
por: Cho, Won Kyung, et al.
Publicado: (2023)

Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic Factors
por: Jeong, Dong Young, et al.
Publicado: (2020)

Feasibility and Safety of a New Chest Drain Wound Closure Method with Knotless Sutures
por: Kim, Min Soo, et al.
Publicado: (2018)

Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma
por: Duque-Santana, Victor, et al.
Publicado: (2022)

Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon
por: Valkema, Maria J, et al.
Publicado: (2023)

Management of patients with bilateral recurrent laryngeal nerve paralysis following esophagectomy
por: Jeon, Yeong Jeong, et al.
Publicado: (2021)

A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell Carcinoma
por: Lim, Sung Hee, et al.
Publicado: (2017)

Treatment modality and outcomes among early-stage non-small cell lung cancer patients with COPD: a cohort study
por: Kang, Noeul, et al.
Publicado: (2020)

Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography
por: Lee, Ji Young, et al.
Publicado: (2019)

Association between Sarcopenia and Physical Function among Preoperative Lung Cancer Patients
por: Kong, Sunga, et al.
Publicado: (2020)

Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer
por: Noh, Jae Myoung, et al.
Publicado: (2015)

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
por: de Klerk, Leonie K., et al.
Publicado: (2021)

Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
por: An, Ji Yeong, et al.
Publicado: (2013)

Management of chyle leakage after general thoracic surgery: Impact of thoracic duct embolization
por: Jeon, Yeong Jeong, et al.
Publicado: (2021)

Psychometric Validation of the Korean Version of the Cancer Survivors’ Unmet Needs (CaSUN) Scale among Korean Non–Small Cell Lung Cancer Survivors
por: Kang, Danbee, et al.
Publicado: (2023)

Surgically resected T1‐ and T2‐stage esophageal squamous cell carcinoma: T and N staging performance of EUS and PET/CT
por: Jeong, Dong Young, et al.
Publicado: (2018)

Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients
por: Yoon, Han Gyul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_99it7685vmhd5n4p9g73r7e7jq